Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma
{{output}}
Background: Anaplastic large cell lymphoma (ALCL) constitutes 10-15% of childhood non-Hodgkin lymphoma. EFS is 70% and currently 80% with the additional of targeted agents such as CD30 directed conjugated monoclonal antibody bren... ...
